WATSON PHARMACEUTICALS, INC., as Issuer and Wells Fargo Bank, National Association, as Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of May 7, 2010 to the Indenture dated as of August 24, 2009 5.000% Senior Notes due 2014 6.125% Senior Notes due 2019Supplemental Indenture • May 10th, 2010 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of May 7, 2010, between WATSON PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee (the “Trustee”).
CONSULTING AGREEMENTConsulting Agreement • May 10th, 2010 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • London
THIS CONSULTING AGREEMENT (“Agreement”) is made effective as of the 10th day of May, 2010, by and between Arrow No. 7 Ltd., a United Kingdom corporation (“Company”) and Anthony Selwyn Tabatznik (“Consultant”).
